Figure 1.
Figure 1. Histograms demonstrating intracellular SH2D1A expression in patients with XLP. Flow cytometric analysis of intracellular SH2D1A expression. (A) Representative healthy control. (B) Normal expression, the father of patient 5 (P5). (C) XLP carrier, the mother of patient 1. P1 to P4 (D-G) are patients with confirmed mutations of the SH2D1A gene. Lymphocytes are gated and stained with anti-SH2D1A antibody (continuous lines) or irrelevant rat IgG (dashed lines) and additional FITC-labeled, antirat IgG antibody. *SH2D1A expression in CD56+ T cells of patient 3 was not measured (N/A) because the number of CD56+ T cells in his sample was too low.

Histograms demonstrating intracellular SH2D1A expression in patients with XLP. Flow cytometric analysis of intracellular SH2D1A expression. (A) Representative healthy control. (B) Normal expression, the father of patient 5 (P5). (C) XLP carrier, the mother of patient 1. P1 to P4 (D-G) are patients with confirmed mutations of the SH2D1A gene. Lymphocytes are gated and stained with anti-SH2D1A antibody (continuous lines) or irrelevant rat IgG (dashed lines) and additional FITC-labeled, antirat IgG antibody. *SH2D1A expression in CD56+ T cells of patient 3 was not measured (N/A) because the number of CD56+ T cells in his sample was too low.

Close Modal

or Create an Account

Close Modal
Close Modal